Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance (Project BEST)
|ClinicalTrials.gov Identifier: NCT00622596|
Recruitment Status : Completed
First Posted : February 25, 2008
Last Update Posted : August 24, 2016
|Condition or disease||Intervention/treatment|
|Opiate Dependence||Other: Mobile Access|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||200 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance|
|Study Start Date :||October 2003|
|Primary Completion Date :||September 2008|
|Study Completion Date :||September 2008|
Experimental: Mobile Access to Buprenorphine
High risk populations accessing a mobile health care system can obtain Buprenorphine for treatment.
Other: Mobile Access
Subjects would access buprenorphine through mobile access. On day 1: 8 mg of buprenorphine, then on Day 2: 16 mg daily of buprenorphine sublingually.
- Attendance [ Time Frame: 10/1/03-9/30/08 ]To assess the feasibility and efficacy of the use of buprenorphine to treat opioid dependence in high risk populations accessing a mobile health care system using tracked attendance.
- Opioid free urine toxicology [ Time Frame: 10/1/03-9/30/08 ]To assess the feasibility and efficacy of the use of buprenorphine to treat opioid dependence in high risk populations accessing a mobile health care system using incidence of opioid free urine toxicology.
- Access to other health care, incarceration, hospitalization acceptability of the site of care from both patient and provider perspectives, and attendance and adherence to counseling. [ Time Frame: 10/1/03-9/30/08 ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00622596
|United States, Connecticut|
|Yale University School of Medicine|
|New Haven, Connecticut, United States, 06510|
|Principal Investigator:||Frederick L Altice, MD||Yale University School of Medicine/AIDS Program|